D2-40 antibody is raised against an oncofetal antigen, the M2A antigen. It has been used as a marker for lymphatic endothelium as well as mesothelioma and cerebellar hemangioblastoma. We demonstrate here that positive D2-40 immunoreactivity was found in the developing cerebrum, particularly in the germinal matrix layer, immature ependyma, choroid plexus and meninges. In the developing cerebellum, positive D2-40 immunoreactivity was found in the external granular layer particularly of the outer portion and the Purkinje cell layer as well as meninges. Some brain tumors such as anaplastic ependymoma, some medulloblastomas, glioblastoma, pineal germinoma, craniopharyngioma, choroid plexus papilloma, choroid plexus carcinoma, and meningioma showed positive immunoreactivity with D2-40. Therefore, D2-40 antibody is considered a useful marker for research on developing brain and diagnosis of brain tumors, differentiation between choroid plexus carcinoma and metastatic carcinoma. In addition, on cultured human neural cells, D2-40 immunoreactivity was found in nestin-positive neural stem/progenitor cells and neuronal lineage cells. As D2-40 antibody recognizes cell surface antigen M2A, it might be a candidate cell surface marker for isolation of human neural stem cells/ neuronal lineage cells in the fluorescence-activated cell sorting technique.
D2-40 is a novel monoclonal antibody against an oncofetal antigen, the M2A antigen, consisting of a 40-kDa sialoglycoprotein with an O-linked simple mucin-type carbohydrate structure. 1 This antibody was originally considered to be useful for confirming histological diagnosis of seminoma and dysgerminoma. [1] [2] [3] However, a recent study suggested D2-40 to be a new selective monoclonal immunohistochemical marker of lymphatic endothelium on formalin-fixed and paraffin-embedded tissue specimens. 4, 5 The antibody was applied for evaluation of lymphatic invasion and clinical correlation of various neoplasms such as squamous cell carcinoma in the head and neck region, 6 of the uterine cervix, 7 and breast carcinoma. 8 The positive immunoreactivity with D2-40 antibody was demonstrated in kaposiform hemangioendothelioma suggesting that this tumor could undergo partial differentiation along the lymphatic endothelial lineage. 5, 9 D2-40 antibody is also a sensitive marker of mesothelioma and useful in differential diagnosis of mesothelioma vs adenocarcinoma. 10, 11 One report suggested that the D2-40 antibody specifically recognized human podoplanin and hypothesized podoplanin to be identical to the M2A antigen. 12 In the central nervous system tissue, vacuolated cells found in cerebellar hemangioblastoma were demonstrated to be strongly positive with D2-40 antibody, and D2-40 is a useful marker to distinguish hemangioblastoma from metastatic clear cell renal cell carcinoma.
In the search for immunohistochemical markers of the developing human brain, we raised several novel antibodies such as tubulin beta II as a neural stem cell and neuronal cell lineage marker, 14 and KIAA0864 protein as a Purkinje cell and its dendrite/axon marker. 15 Several commercially available antibodies such as nestin, vimentin and GFAP were also evaluated. During the study, we found strong positive immunoreactivity with D2-40 antibody in the germinal matrix layer of the human developing brain. This incidental finding promoted us to study the immunoreactivities with the D2-40 antibody in cultured human neural stem/progenitor cells and their derivatives as well as the developing human cerebrum, cerebellum and some brain tumors.
Materials and methods

Materials
Cerebrum samples for immunohistochemical study were obtained from spontaneous abortion or at autopsy from 34 cases ranging from 6 gestational weeks to 59 years (two cases each at 6 and 19 gestational weeks, one case each at 7, 8, 9, 10, 11, 14, 15 and 18 gestational weeks, nine cases at 20-29 gestational weeks, five cases at 30-40 gestational weeks, three cases at 1-6 months of age, one at 1 year, one at 5 years and three at 30-59 years). Cerebellum samples were from 25 cases out of the 34 cases ranging from 8 gestational weeks to 59 years (one case each at 8, 9, 10, 14, 15, 18 and 19 gestational weeks, five cases at 20-29 gestational weeks, five cases at 30-40 gestational weeks, three cases at 1-6 months of age, one at 1 year, one at 5 years and three at 30-59 years). Most samples (22 out of 34 cases) were obtained at autopsy within 12 h after death. Brain tumor samples were obtained from biopsy and resected materials of 34 cases (four ependymal tumors, four medulloblastomas, three astrocytomas grade 2, five glioblastomas, three cases of pineal germinoma, six craniopharyngiomas, four choroid plexus tumors and five meningiomas). Six cases of papillary carcinoma in other tissues (thyroid gland, breast, pancreas, ovary and colon) were also prepared. Ten percent buffered formaldehyde-fixed and paraffin-embedded sections from all samples were prepared for immunohistochemistry. Human fetal forebrain tissues (between 7 and 10 gestational weeks) were collected from the Osaka National Hospital for the culture of neural stem/ progenitor cells. This study was carried out in accordance with the principles of the Helsinki Declaration and was approved by the Ethical Committee of each institution.
Light Microscopic Immunohistochemical Study
Paraffin-embedded specimens were used for light-microscopic immunohistochemistry. Lightmicroscopic immunohistochemical staining was performed with a commercially available kit (Histofine HER 2 kit, Nichirei, Tokyo, Japan) colored with diaminobenzidine according to the manufacturer's instructions. In this study, commercially available mouse monoclonal antibodies D2-40 from two companies (Nichirei, Tokyo, Japan and Signet, Dedham, MA, USA) were used. Other commercially available antibodies against nestin (rabbit polyclonal, Chemicon, Temecula, CA, USA), vimentin (mouse monoclonal, DAKO, Carpinteria, CA, USA) and GFAP (mouse monoclonal, DAKO) were used as markers of neural stem cell/progenitor cell and glial lineage cells. Our raised antibody HFB-16 against KIAA0864 protein (as a marker for cerebellar Purkinje cell and its dendrite/axon) 15 was also applied. The slides were pretreated (antigen rescue) by microwaving them for 15 min in 10 mM citrate buffer at pH 6.0 or incubating them in a hot water bath (951C, 40 min) in the same buffer. The dilutions of primary antibodies were 1:50 (D2-40, Signet), 1:100 (D2-40, Nichirei), 1:200 (nestin, vimentin and GFAP) and 1:1000 (HFB-16). For controls, the primary antibodies were omitted or primary antibodies preadsorbed with excess brain homogenate or normal sera were used. Hematoxylin and eosin (HE) staining was also performed.
The percentage of positive immunoreactivity was classified into four groups: intense, 450% of cells labeled; moderate, 5-50% of cells labeled; weak, o5% of tumor cells labeled; and negative, no staining.
Human Neural Stem/Progenitor Cells Culture and Differentiation
Human fetal forebrain tissues (between 7 and 10 gestational weeks) were collected from the Osaka National Hospital. Approval was obtained from both the Osaka National Hospital and the Tissue Engineering Research Center local ethic committees. Samples were mechanically dissected in Dulbecco's-modified Eagle's Medium (DMEM)/Ham's F-12 (1:1). After dissection, tissue samples were incubated in 0.05% trypsin and 0.5 mM EDTA (Invitrogen, Carlsbad, CA, USA) for 20 min at 371C. Enzymatic activity of trypsin was inhibited by trypsin inhibitor (Roche Diagnostics Corporation, Indianapolis, IN, USA). Cell suspensions were grown using the neurosphere method 16 in a defined DMEM/F-12 (1:1)-based growth medium supplemented with human recombinant (hr-) epidermal growth factor (20 ng/ml, Invitrogen), hr-fibroblast growth factor 2 (20 ng/ml, PeproTech Inc, Rocky Hill, NJ, USA), hr-LIF(10ng/ml, Chemicon), heparin (5 mg/ml, Sigma, St Louis, MS, USA), B27 supplement (Invitrogen), 15 mM HEPES as previously reported. 14, 16, 17 To induce differentiation, neurospheres were plated on poly-ornithine-coated glass coverslips and cultured in the medium with all D2-40 in brain Y Nakamura et al three growth factors withdrawn and supplemented with 1% FBS. Cells were cultured for 14 days before fixation for immunocytochemistry.
Immunocytochemical Analysis
The neurospheres were fixed in phosphate-buffered saline (PBS) containing 4% paraformaldehyde (PHA) for 20 min at room temperature. After fixation, the neurospheres were dipped in 30% sucrose in PBS for 30 min at room temperature, embedded in OCT-compound (Sakura Finetechnical, Tokyo, Japan) and sectioned at 12 mm on a cryotome. The differentiated cells were also fixed in PBS containing 4% PHA for 20 min at room temperature. Frozen sections of neurospheres were incubated with two primary antibodies to nestin (rabbit polyclonal; 1:500) 14 and D2-40 in PBS/0.1% Triton-X/10% normal goat serum at 41C overnight. Nuclei were stained with TO-PRO-3 s (Molecular Probes Inc., Eugene, OR, USA). Coverslips were incubated with another set of two primary antibodies against D2-40, the polysialic acid-neural cell adhesion molecules (PSA-NCAM) (mouse IgM; kindly gifted by Dr Seki, Department of Anatomy, Juntendo University School of Medicine, 1:500), 18 or GFAP (rabbit poly, Sigma, 1:80) with TO-PRO-3 s in the same reaction conditions. After three washes, neurosphere sections and coverslips were incubated with adequate secondary antibodies (Alexa Fluor s 488 goat anti-mouse IgG, Alexa Fluor s 568 goat anti-rabbit or mouse IgG, and Alexa Fluor s 488 goat anti-mouse IgM, Molecular Probes Inc.) at room temperature for 1 h. Sections and coverslips were examined using laser-scanning microscope (Carl Zeiss LSM510).
Results
D2-40 Immunoreactivity in Developing Human Cerebrum
Both commercially available D2-40 antibodies from Nichirei and Signet revealed the same results, therefore each antibody is applicable and obtained reproducible results.
In the 6 gestational weeks cerebrum, the positive immunoreactivity with D2-40 was found throughout the entire zone of the cerebrum in a fibrous and reticular pattern. Compared with immunoreactivities with nestin, which were mainly positive in the radial fibers, D2-40 immunopositivity was found more diffusely, including on the surface of radial fibers and migrating neuroblasts ( Figure 1 ). In 8-14 gestational weeks, the range of positive immunoreactivity became decreased and restricted to the deep white matter and the germinal matrix layer. In 15 gestational weeks, intense positive immuno- reactivity was seen in and around the germinal matrix layer, ependymal cells and leptmeninges. During 18-29 gestational weeks, the germinal matrix layer was localized and became prominent over the caudate head, over the caudate-thalamic groove, over the caudate tail along the inferior horn, and along the trigone of the lateral ventricle. The localized germinal matrix layer was intensely immunopositive with D2-40 as well as vimentin ( Figure 2 ). Compared with vimentin immunoreactivity, D2-40 positivity was more diffusely distributed in the matrix as well as cellular component in the germinal matrix layer. Vimentin and GFAP positivity was found in glioblasts and mature astrocytes; however, D2-40 positivity was seen only in glioblasts and not in mature astrocytes. After 30 gestational weeks, the germinal matrix layer became regressed and cellular components in the germinal matrix layer decreased rapidly in number. However, D2-40 immunoreactivity remained as intense in ependymal cells and as moderately intense as in the germinal matrix layer (Figure 3a) . Compared with GFAP and vimentin, which was positive in astrocytes found in the deep white matter, D2-40 immunoreactivity was only weakly seen in deep white matter. In adult brains, weak-moderate immunoreactivity with D2-40 was found in the ependymal and subependymal region (Figure 3b (Figure 5c ). After birth (up to 1 year of age), the distribution of D2-40 immunoreactivity remained around fully developed dendrites and the immunoreactivity along the nerve fibers appeared to be intensified. Around 1 year of age, the external granular layer disappeared and intense immunoreactivity in the external granular layer also disappeared; however, moderate immunoreactivity in leptomeninges remained. In the adult cerebellum, D2-40 moderate immunoreactivity was found along the mature dendrites of the Purkinje cells in the molecular layer, on the surface of Purkinje cells, along nerve fibers in the white matter and leptomeninges. The internal granular layer showed negative staining throughout the fetal, infant and adult stages except for the neural fibers from Purkinje cells.
A summary of D2-40 immunohistochemistry in the different stages of developing cerebrum and cerebellum is shown in Table 1 .
D2-40 Immunoreactivity in Brain Tumors
One case of ependymoma showed weak immunoreactivity and another case showed intense immunoreactivity with D2-40. Both cases of anaplastic ependymoma showed intense immunoreactivity with D2-40 (Figure 6a) . Out of four cases of medulloblastoma, two cases revealed weak to moderate immunoreactivity in some differentiated cell components (Figure 6b) . Two other cases were almost completely negatively stained. All three astrocytomas showed negative to weak immunopositivity with D2-40. In two out of five cases of glioblastoma, weak immunoreactivity was seen. Three cases showed moderate immunoreactivity (Figure 6c ). All three cases of pineal germinoma revealed intense immunoreactivity with D2-40 on the surface of tumor cells (Figure 7a) . In all six cases of craniopharyngioma, intense immunoreactivity was found in the epithelial components of this tumor, while negative or weak positivity in the stroma was observed (Figure 7b ). All three cases of choroid plexus papilloma showed intense positive immunoreactivity with D2-40 along the apical surface of the tumor epithelium. A single case of choroid plexus carcinoma showed moderate A summary of the immunoreactivity in brain tumors is shown in Table 2 .
D2-40 Immunoreactivity on Human Cultured Neural Cells
The majority of cells within neurospheres were positively immunostained with D2-40 antibody on the surface of neural stem cells as well as nestin antibody in the cytoplasm of neural stem cells ( Figure  8 ). After induction of differentiation, the distribution of immunoreactivity of D2-40 was similar to that of PSA-NCAM, indicating expression in the neuronal differentiated lineage (Figure 9a) . Only a small number of D2-40-positive cells seemed to share the positive immunoreactivity to GFAP (Figure 9b ).
Discussion
This is the first report that demonstrated intense immunoreactivity in the germinal matrix layer of human developing cerebrum and cultured neural cells. In the developing human cerebrum, neural stem/progenitor cells proliferate in the germinal matrix layer, thereafter a series of neuronal migrations occur during which postmitotic neuroblasts leave the germinal matrix layer and move to the cortical plate along radial guidance fibers. 19 Several immunohistochemical markers for the germinal matrix layer cells and radial guidance fibers have been reported. Nestin is the product of a newly found gene encoding a protein classified as a distinct sixth class of intermediate filaments. 20 It has been reported to express in the germinal matrix layer cells and radial fibers during the neuronal migration and be gradually replaced by vimentin. 21, 22 D2-40 immunoreactivity was intensely found in the germinal matrix layer cells and radial fibers in 6 gestational weeks and thereafter it became restricted in and around the germinal matrix layer gradually. In the germinal matrix layer, the cell surface of ependymal cells, neural stem/progenitor cells and glioblasts were intensely immunoreactive with D2-40 during 8-30 gestational weeks. After regression of the germinal matrix layer, D2-40 immunoreactivity remained in ependymal cells and matrices of the periventricular region. D2-40 immunoreactivity was found in glioblasts temporally but not in that podoplanin is identical to the M2A antigen, which was recognized by the D2-40 antibody. 12 The results of our study (D2-40 positivity in choroid plexus, ependyma and meninges) support their hypothesis.
Intense D2-40 staining on the cell surface of Purkinje cells and their dendritic processes was GW: gestational weeks; y: year old; GML: germinal matrix layer; WM: white matter; EP and SEP: ependymal and subependymal; EGL: external granular layer; MOL: molecular layer; PUR: Purkinje cell layer; À: negative, no staining; +: weak, o5% of cells in the laeyr labeled; ++: moderate, 5-50% of cells labeled; +++: intense, 450% of cells labeled.
D2-40 in brain Y Nakamura et al described in the non-neoplastic cerebellar cortex found incidentally during the search for D2-40 immunoreactivity in cerebellar hemangioblastoma. 13 Our study confirmed the observation of D2-40 immunoreactivity on the cell surface of Purkinje cells and their dendritic processes 13 and first described that intense D2-40 staining was seen in the outer part of the external granular layer. Monoclonal antibodies against MAP2, IP3R1 and KIAA0864 protein have been used to detect Purkinje cells with immunohistochemistry in formalin-fixed and paraffin-embedded brain samples from normal development 15, 23, 24 and diseased brains. 25, 26 This study has shown that while HFB-16 (antibody against KIAA0864 protein) immunoreactivity was found only in the cytoplasm of Purkinje cell and its dendrite/axon, D2-40 immunoreactivity was seen on the surface of and around Purkinje cell and its dendrite/axon as well as the external granular layer. In the human cerebellum, neuroblasts migrate radially outward from the germinal matrix layer in the wall of the fourth ventricle and settle in the deep cerebellar nuclei and the Purkinje cell layer between 9 and 13 gestational weeks. 27 The germinal matrix layer disappears at birth. Another pathway begins at 11 and 13 gestational weeks when the germinative cells migrate tangentially from the germinal matrix layer over the cerebellar surface, forming the external granular layer. Neuroblasts generated from the external granular layer begin to migrate inward around 16 gestational weeks and form the basket and stellate cells of the molecular layer and finally the internal granular layer. Thus, Purkinje cells and the external granular layer/internal granular layer are differently developed; however, D2-40 antibody recognized both Purkinje cells and external granular layer cells, but not external granular layer cells. In the cerebrum, no mature neurons showed positive immunoreactivity with D2-40. It is uncertain why only Purkinje cell neurons showed positive immunoreactivity with D2-40 along with external granular layer cells.
Both in ependymal tumors and astroglial tumors, less differentiated tumors revealed more positive immunoreactivities with D2-40. Medulloblastoma, the most primitive tumor in this study and considered to be of the external granular layer origin, showed positive immunoreactivity in part of some differentiated cell component. Several reports showed higher expression of selective makers of neural stem/progenitor cells, like nestin or musashi1, in malignant gliomas suggesting the biological analogy between neural stem/progenitor cells and glioma cells and the usefulness of these markers for clinical diagnosis of malignant gliomas. 21, 28 Present findings suggest D2-40 may be a useful marker for characterizing tumor properties and for examining in situ the analogy between normal neural stem/ D2-40 in brain Y Nakamura et al progenitor cells and brain tumor cells. The result that pineal germinoma was intensely positively stained with D2-40 is reasonable because of positivity in seminoma and dysgerminoma. [1] [2] [3] Intense immunoreactivity in the epithelial components of craniopharyngioma was expected because the positive staining in basal keratinocytes of the normal skin and skin cancer was reported. 12 Intense immunoreactivity in choroid plexus papilloma was also predictable because the presence of positive staining in normal choroid plexus was determined in this study and a previous study. 12, 29 Moderate immunopositivity in choroid plexus carcinoma is very useful in differentiating from metastatic papillary carcinoma. All six cases of papillary carcinoma in other organs such as thyroid gland, breast, pancreas, ovary and colon showed completely negative staining with D2-40. The diagnosis of choroid plexus carcinoma is usually very difficult; therefore, the demonstration of the positive immunoreactivity with D2-40 could be a strong tool for differential diagnosis of choroid plexus carcinoma and metastatic papillary carcinoma. Normal leptomeniges in developing and adult brain and meningioma showed moderate-intense immunopositivity with D2-40.
From cultured neural cells study, intense D2-40 immunoreactivity was confirmed in nestin-positive neural stem/progenitor cells. Moreover, D2-40-positive immunoreactivity was found in neuronal progenitor cells and developing neuron, that express PSA-NCAM. 18 These findings indicate that human neural stem/progenitor cells and/or neuronal lineage cells express D2-40 antigen. In developing human brain tissues and differentiation-induced neural stem/progenitor cells, some cells shared positive immunoreactivity with both GFAP and D2-40 suggesting that D2-40 antigen is expressed in progenitor cells of glial differentiation (glioblasts).
A recent study has demonstrated that neural stem cells can differentiate into endothelial lineage. 30 And more, it is reported nestin-positive human neural stem/progenitor cells highly express ATPbinding cassette (ABC) transporters, like ABCB1 31 or ABCG2 (breast cancer resistance protein), 32 that are generally expressed in endothelial cells in normal brains. 33, 34 It is also reported nestin is expressed in proliferative endothelial cells. 35, 36 Taken together, these previous findings and our present study suggest that both neural stem/progenitor cells and vascular and/or lymphatic endothelial cells share the same antigens and there might be some developmental analogies between them. Further investigation of the relationship between neural stem/progenitor cells and vascular and/or lymphatic endothelial cells will contribute greatly to our understanding of their biological properties. In addition, D2-40 antibody could be a candidate as a useful cell surface marker for isolation of human neural stem/progenitor cells and/or neuronal lineage cells in techniques such as fluorescence-activated cell sorting [37] [38] [39] and will contribute to establishing new strategies for culturing human neural stem/progenitor cells intended for clinical applications.
